Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S8-S14. doi: 10.18553/jmcp.2020.26.12-b.s8
Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S3-8. doi: 10.18553/jmcp.2020.26.12-b.s3
Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S14-20. doi: 10.18553/jmcp.2020.26.12-b.s14
Dillon R, Colosia A, Khan S, Masaquel C, McCann E. A systematic literature review of the efficacy and tolerability of polymyxins in resistant Gram-negative infections. Poster presented at the Virtual 2020 30th European Congress of Clinical Microbiology and Infectious Diseases; April 2020. [abstract] ECCMID Abstract Book. 2020 Apr; p.2602.
Rycroft CE, Pearson IV, Khan S, Heyes AE. A tale of four countries: comparing reimbursement submission requirements in Ireland, England, Wales, and Scotland. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A418-9.
Chirila C, Odom D, Devercelli G, Khan S, Sherif B, Kaye J, Molnar I, Sherrill B. Meta-analysis of the validity of progression-free survival as a surrogate endpoint for overall survival in metastatic colorectal cancer trials. Poster presented at the 35th European Society for Medical Oncology Congress; October 12, 2010. [abstract] Ann Oncol. 2010 Oct; 21(suppl 8):623P.
Khan SB, Peltz G, Pohl G, Liu E, Copley-Merriman K, Colosia AD. Impact of patient/provider communications on quality of care for cancer. Poster presented at the 3rd Conference of the American Association for Cancer Research; October 2010.
Colosia AD, Khan SB, Peltz G, Pohl G, Liu E, Kaye JA. Electronic medical records: quality cancer care and cost-effectiveness. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 26, 2010. [abstract] Value Health. 2010 May; 13(3):A52.
Khan SB, Faulkner E, Watkins J, Polkus V. Making a case for value: differences in dossier development and value communication for pharmaceuticals versus diagnostics and medical devices. Presented at the 2010 ISPOR 15th Annual International Meeting; May 2010. Atlanta, GA.
Faulkner EC, Khan SB. Dossiers for diagnostics or medical devices. Poster presented at the 22nd Annual Meeting and Showcase of the Academy of Managed Care Pharmacy; April 2010.